2013 Concentrates Epilepsy Treatment 
The Cannigma
JUNE 15, 2021
The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. CBG, however, also has some medicinal potential that CBD doesn’t, for instance as a treatment for hypertension and insulin resistance. Shutterstock).
Cannabis Law Report
JUNE 8, 2021
Currently, the development of effective drugs based on CBD for the treatment of Alzheimer’s disease, dementia, diabetes, and epilepsy is underway. External use allows the production of creams and cosmetics for skin care, balms for muscles and joints treatment, cosmetics for bathing, hair care products. In 2018, the U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
CannaEffect
JUNE 12, 2017
In June 2013 when Beyla was two-years-old, she had her first seizure. Even when treated, the Epilepsy Foundation said seizures can make it difficult for kids to do well in school, can cause depression and anxiety, and can lead to unexplained injuries and illnesses. It was any parent’s nightmare.
Cannabis Law Report
JULY 12, 2019
Ultimately, the cannabinoid system works by way of multiple molecules affecting multiple receptors at once – the entourage effect, and thus such singular approaches to treatment by way of the cannabinoid system are not effective. An Israeli study of cannabis versus epilepsy, however, used natural extracts with a ratio of 20:1 CBD:THC.
Healer
JUNE 28, 2019
Average pain, worst pain and sleep disruption were measured daily during 5 weeks of treatment; other questionnaires measured quality of life and mood. METHODS: We performed a systematic review of medical marijuana (1948-November 2013) to address treatment of symptoms of multiple sclerosis (MS), epilepsy, and movement disorders.
Cannabis Law Report
SEPTEMBER 19, 2019
Medicinal cannabis was technically legalised at the start of November 2018 following several high-profile cases about children with severe forms of epilepsy being unable to access potentially life-changing cannabis-based treatment. The firm was founded in 1998 and listed on AIM in 2001 before it left London to join the NASDAQ in 2013.?Over
Cannabis Law Report
SEPTEMBER 23, 2019
The AAFP urges its members to be involved in the diagnosis, treatment, and prevention of substance use, as well as secondary diseases impacted or caused by use. The AAFP recognizes the benefits of intervention and treatment for the recreational use of marijuana, in lieu of incarceration, for all individuals, including youth.
Expert insights. Personalized for you.
122 
Let's personalize your content